A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Johnson & Johnson stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 100,800 shares of JNJ stock, worth $14.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
100,800
Previous 102,229 1.4%
Holding current value
$14.7 Million
Previous $16 Million 0.49%
% of portfolio
0.1%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $13 Million - $14.2 Million
89,328 Added 692.41%
102,229 $16 Million
Q3 2023

Nov 15, 2023

BUY
$155.75 - $174.48 $2.01 Million - $2.25 Million
12,901 New
12,901 $2.01 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $32.7 Million - $39 Million
216,183 New
216,183 $33.5 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $634,026 - $705,513
3,930 New
3,930 $642,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $6.79 Million - $7.53 Million
-43,547 Reduced 82.6%
9,175 $1.57 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $5.97 Million - $6.63 Million
36,966 Added 234.62%
52,722 $8.52 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $2.51 Million - $2.7 Million
15,756 New
15,756 $2.6 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $1.47 Million - $1.68 Million
-10,705 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $2 Million - $2.19 Million
-14,229 Reduced 57.07%
10,705 $1.59 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $2.98 Million - $3.59 Million
23,108 Added 1265.5%
24,934 $3.51 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $202,941 - $281,185
1,826 New
1,826 $239,000
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $8.5 Million - $9.76 Million
-66,662 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $8.46 Million - $9.48 Million
66,662 New
66,662 $8.63 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $431,614 - $474,693
-3,291 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $413,744 - $460,048
3,291 New
3,291 $460,000
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $2.2 Million - $2.59 Million
-18,120 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $3.22 Million - $3.56 Million
-26,983 Reduced 59.83%
18,120 $2.2 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $5.64 Million - $6.68 Million
45,103 New
45,103 $5.78 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $5.11 Million - $5.6 Million
-38,969 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $5.05 Million - $5.28 Million
38,969
38,969 $5.07 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.